title: An expanded prescribing role for pharmacists - an Australian perspective.
abstract: Expanded pharmacist prescribing is a new professional practice area for pharmacists. Currently, Australian pharmacists' prescribing role is limited to over-the-counter medications. This review aims to identify Australian studies involving the area of expanded pharmacist prescribing. Australian studies exploring the issues of pharmacist prescribing were identified and considered in the context of its implementation internationally. Australian studies have mainly focused on the attitudes of community and hospital pharmacists towards such an expansion. Studies evaluating the views of Australian consumers and pharmacy clients were also considered. The available Australian literature indicated support from pharmacists and pharmacy clients for an expanded pharmacist prescribing role, with preference for doctors retaining a primary role in diagnosis. Australian pharmacists and pharmacy client's views were also in agreement in terms of other key issues surrounding expanded pharmacist prescribing. These included the nature of an expanded prescribing model, the need for additional training for pharmacists and the potential for pharmacy clients gaining improved medication access, which could be achieved within an expanded role that pharmacists could provide. Current evidence from studies conducted in Australia provides valuable insight to relevant policymakers on the issue of pharmacist prescribing in order to move the agenda of pharmacist prescribing forwards.
authors: Curtin Health and Innovation Research Institute, School of Pharmacy, Curtin University, Perth, WA, Australia.
authors: Kreshnik
authors: K
authors: Hoti
authors: Jeffery
authors: J
authors: Hughes
authors: Bruce
authors: B
authors: Sunderland
keywords: Australia; Australian pharmacy; Pharmacist prescribing; non-medical prescribing; pharmacy clients
references: Am J Health Syst Pharm. 1995 Aug 1;52(15):1696-9
references: 7583834
references: Hosp Formul. 1990 Jan;25(1):67-8, 76-8, 80
references: 10103538
references: J Pharm Pharm Sci. 2005 Aug 04;8(2):217-25
references: 16124933
references: Int J Pharm Pract. 2010 Feb;18(1):29-36
references: 20405593
references: Am J Health Syst Pharm. 1995 Aug 1;52(15):1732
references: 7583839
references: J Health Serv Res Policy. 2008 Oct;13(4):215-21
references: 18806179
references: Ann Pharmacother. 2009 Jun;43(6):1115-21
references: 19417108
references: J Clin Pharm Ther. 2008 Feb;33(1):11-6
references: 18211611
references: Int J Pharm Pract. 2011 Feb;19(1):5-12
references: 21235654
references: JAMA. 2009 Feb 25;301(8):858-60
references: 19244193
references: Am J Health Syst Pharm. 2004 Jul 15;61(14):1429
references: 15332684
references: Med Care. 1983 Apr;21(4):435-44
references: 6843196
references: Can J Hosp Pharm. 2010 May;63(3):267-74
references: 22478988
references: Am J Health Syst Pharm. 2008 Nov 15;65(22):2152-3
references: 18997146
references: Health Policy. 2008 Mar;85(3):277-92
references: 17900744
references: Am J Health Syst Pharm. 2008 Nov 15;65(22):2126-32
references: 18997141
references: S Afr Med J. 1993 Nov;83(11):822-3
references: 7839211
references: Pharmacotherapy. 2003 Sep;23(9):1210-25
references: 14524655
references: Int J Pharm Pract. 2009 Apr;17(2):89-94
references: 20214256
references: Am J Health Syst Pharm. 2004 Aug 1;61(15):1609-10
references: 15372838
references: CMAJ. 2007 Sep 11;177(6):558
references: 17715244
references: J Clin Pharm Ther. 2007 Dec;32(6):545-56
references: 18021331
references: Nurs Stand. 2005 Aug 31-Sep 6;19(51):51-6
references: 16161516
references: Pharm World Sci. 2006 Apr;28(2):76-90
references: 16791716
references: Pharm World Sci. 2010 Oct;32(5):610-21
references: 20683674
references: Am J Health Syst Pharm. 2009 Mar 1;66(5 Suppl 3):S13-9
references: 19233967
references: J Antimicrob Chemother. 2007 Mar;59(3):333-41
references: 17289771
references: Fam Pract. 2010 Feb;27(1):110-20
references: 19858124